课题基金 / 基金详情

Genomic aberrations by chemoradiotherapy in children and its transfer to next generation

Genomic aberrations by chemoradiotherapy in children and its transfer to next generation
儿童放化疗引起的基因组畸变及其遗传给下一代
批准号:
25670743
负责人:
HIYAMA Eiso
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Challenging Exploratory Research
财政年份:
2013
资助国家:
日本
项目状态:
已结题
起止时间:
2013-04-01 至 2014-03-31

项目摘要

项目成果

HIYAMA Eiso的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To analyze the genomic transmission from the childhood cancer survivors to their future generation, pre- and post-therapeutic genomes in the 26 pairs of the patients and their children were examined using Cytoscan microarray which had more than 2,700,000 SNP (single nucleotide polymorphism) signals. All cases showed mutation, deletion, and insertion in 43 -3,123 (mean 623) loci in their genome and the numbers of altered loci is more in the patients who received radiotherapy. These genomic aberrations were significantly correlated with the use of anthracyclin chemotherapy.In the analysis of their childhood genomes in the comparison with each parent genome, transferred aberrations were suspected in 3 of 24 pairs and all 3 cases were derived from female survivors. From these data, some of these aberration in the survivors were transmitted to the next generation.
期刊论文(67)
专著(0)
科研奖励(0)
会议论文
Wilms腫瘍を合併した縦隔奇形腫の1例
纵隔畸胎瘤并发肾母细胞瘤一例
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [小倉薫,檜山英三,鬼武美幸,上田祐華, 他]
通讯作者:
Towards an international pediatric liver tumor consensus classification : proceedings of the Los Angeles COG liver tumors symposium
迈向国际儿科肝脏肿瘤共识分类:洛杉矶 COG 肝脏肿瘤研讨会记录
DOI: 10.1038/modpathol.2013.8
发表时间: 2013
期刊: Modern Pathology
影响因子: 7.5
作者: [Lopez-Terrada D, Hiyama E, et al]
通讯作者: et al
血中DNA を用いた神経芽腫の分子診断:予後予測と治療効果判定
使用血液 DNA 进行神经母细胞瘤的分子诊断:预测预后并确定治疗效果
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [本多 昌平, 岡田 忠雄,宮城 久之,檜山 英三, 武冨 紹信, 檜山 英三,児島 正人,河島 茉澄,上田 祐華,鬼武 美幸,上松瀬 新,小倉 薫,末田 泰二郎]
通讯作者: 檜山 英三,児島 正人,河島 茉澄,上田 祐華,鬼武 美幸,上松瀬 新,小倉 薫,末田 泰二郎
FURTHER STUDY: IDENTIFICATION OF NEW CANDIDATE GENES IN PROGRESSION OF HEPATOBLASTOMA USING GENOME-WIDE ASSOCIATION STUDY
进一步研究:利用全基因组关联研究鉴定肝母细胞瘤进展中的新候选基因
DOI: --
发表时间: 2013
期刊:
影响因子: --
作者: [Hiyama E, Ueda Y, Onitake Y, Ida K, Ogura K, Kondo S, Kamijyo T, Watanabe K, Oue T, Hishiki T, Tajiri T, Horie H, Inoue T, Tanaka Y]
通讯作者: Tanaka Y
21
    Analysis of genomic aberrations, risk of secondary cancer development and, hereditary effects by irradiation and chemotherapy in children
    • 批准号:
      26670764
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2014
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Detection of molecular targets for childhood cancers using genomics and cellomics: targeting for cancer stem cells
    • 批准号:
      24249084
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.37万
    • 财政年份:
      2012
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Survey of childhood liver tumors in Asian area and infrastructural development of international collaboration study by Japanese study group for pediatric liver tumors (JPLT)
    • 批准号:
      23256006
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.29万
    • 财政年份:
      2011
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    Elucidation of development mechanism and molecular targets in neuroblastoma and hepatoblastoma using genomics and cellomics
    • 批准号:
      21390474
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      HIYAMA Eiso
    • 依托单位:
    国内基金
    海外基金
    TBK1通过磷酸化SLC7A11调控铁死亡抵抗促进鼻咽癌恶性进展的机制研究
    • 批准号:
      2026JJ50595
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王维圆
    • 依托单位:
    CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
    • 批准号:
      2026JJ50313
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      胡希恒
    • 依托单位:
    基于“人源化”新型近红外荧光探针的构建及其在膀胱癌诊疗一体化中的应用研究
    棕榈酰化修饰调控肾透明细胞癌恶性进展
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      金鑫
    • 依托单位: